Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
Top Cited Papers
Open Access
- 23 September 2009
- Vol. 339 (sep23 1) , b3569
- https://doi.org/10.1136/bmj.b3569
Abstract
Read the full review for this F1000Prime recommended article: Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.Keywords
This publication has 21 references indexed in Scilit:
- Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth DefectsNew England Journal of Medicine, 2007
- Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factorsClinical Therapeutics, 2007
- Antidepressant drugs during pregnancy and infant congenital heart defectReproductive Toxicology, 2006
- Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studiesPharmacoepidemiology and Drug Safety, 2005
- Risks Associated With Selective Serotonin Reuptake Inhibitors in PregnancyObstetrics & Gynecology, 2005
- Prevalence of Depression During Pregnancy: Systematic ReviewObstetrics & Gynecology, 2004
- Outcomes of Prenatal Antidepressant ExposureAmerican Journal of Psychiatry, 2002
- Cohort study of depressed mood during pregnancy and after childbirthBMJ, 2001
- Delivery outcome after the use of antidepressants in early pregnancyEuropean Journal of Clinical Pharmacology, 1999
- Birth Outcomes in Pregnant Women Taking FluoxetineNew England Journal of Medicine, 1996